GlassScriptPhysician profile
Erin N Cantu
NPI 1184274185
$3,119.65
in general payments reported to CMS, 2019-2025
18 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $631 · 2022: $964 · 2023: $656 · 2024: $624 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,524.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $829.54 | 2021-2025 | Tremfya, Simponi Aria, Simponi |
| Lilly USA, LLC | $417.74 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Genzyme Corporation | $398.22 | 2021-2025 | |
| Abbvie INC. | $379.99 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $193.94 | 2021-2022 | |
| Amgen INC. | $160.33 | 2021-2024 | Otezla |
| Incyte Corporation | $133.46 | 2021-2023 | Opzelura |
| Ucb, INC. | $124.96 | 2021-2025 | Bimzelx |
| Leo Pharma INC. | $115.43 | 2022-2024 | Adbry |
| Almirall LLC | $90.27 | 2022-2024 | Klisyri, Seysara |
| Regeneron Healthcare Solutions, INC. | $78.61 | 2021-2022 | |
| Biofrontera INC. | $46.48 | 2022-2025 | Xepi, Bf-Rhodoled, Ameluz |
| Arcutis Biotherapeutics, INC. | $36.66 | 2024 | Zoryve |
| Pfizer INC. | $32.59 | 2022 | |
| Dermavant Sciences, INC. | $23.59 | 2024 | Vtama |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.88 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.78 | 2025 | Spevigo |
| Vyne Pharmaceuticals INC. | $16.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Cantu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.